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An Approach to Gene Therapy for Human Melanoma 
Metastatic melanoma is resistant to chemotherapy. In o rder to 
develop a n ew treatment for melanoma , Bonnekoh and coworkers 
(p. 1163) d evised a tes t fo r somatic adenoviral gene therapy, which 
they had used previously in a mouse melanoma model OlD 
104:313-317, 1995) , using human melanoma cells in mice . Initial 
ltudies showed that human melanoma cells in culture were up to 
ten-fold more susceptible to adenoviral infection than mouse 
melanoma cells. T he investigators injected human melanoma cells 
into nude, athymic mice, allowed the cells to form tumors, and 
treated the tumors by injection with a rep lica tion-defective adeno-
virus containing the herpes simplex virus thymjdine kinase (HSV-
tk) gen e . T umor cells transduced by the adenovirus are killed by 
low doses of ganciclovir (GCV), which is non-toxic until phos-
phory lated by HSV-tk, when it becomes an inhibitor of DNA 
synthesis. T hus, any cell that contain s HSV-tk and rcceives GCV is 
killed during cell division , particularly tumor cells, w hicb usua.lly 
divide more fi-equentl y than non-transformed cells. Furthermore 
when killed, transduced tumor cells release phosphorylated GCV: 
creating a significant Hbystander effec t," but the drug is harmless 
except in and around the tumor. Bonnekoh and colleagues found 
that this treatment substantially reduced growth of the tumors and 
produced an 80 percent reduction in a parameter of tumor size, the 
area of res idual viable tumor, in treated animals. Human m elano-
mas in the mice wcre more sensitive than m ouse tumors studjed 
previously. T hese studies suggest that the treatment could eventu-
ally be useful in humans. 
IL-12 Antagonizes UVB-Induced Immunosuppression 
Schwarz e ( al (p. 1187) found that injection of ultravio let-B 
(UVB)-irra diated mice with recombinant murine inte rieukin 
(IL)-12 rescues them from UVB-induced immunosuppression, both 
1 from suppression of contact hypersensitivity and also fro m devel-
opment of to lerance to a hap ten . Although the mechanism ofUVB 
induced in'1munosuppression is no t full y understood, it is known 
that UVB irradiation alte rs the bal ance of T helper cell subsets in 
favor of T b2 cells . This imbalance between T b l and T h2 cells 
appears to lead to suppress ion of contact hypersensitivity and 
induction of tolerance. Since IL-1 2 is a potent stimulator of T hl 
cells, the autho rs asked wbether this cytokille could antagon ize the 
effects of UVB irradiation on couract hyperscnsitivity responses . In 
the authors' experim ents, mice irradiated w ith UV13 do not develop 
contact sensiti vity. If tbe amhors irradiated mice witll UVB and 
then injected them wi th IL-1 2 before sensitizing them, however, 
contact sensiti vity developed normall y. Furthermore, although 
UVB-treated mice usually cannot be rescnsitizcd, because they are 
immunologically to lerant, such mice treated with IL-1 2 could be 
resensitized and reacted vigoro usly to a hap ten alle rgen, dinitroflu-
orobenzene. Since UVB is kn own to induce production of cyto-
kines including IL-I O and tumor necrosis fa ctor-a (T NF-a ), th e 
findings suggest the possibility that IL-12 ma y block or in som e 
other way overcome the efFects of IL-l0 and/ or TNF- a . T hese 
studies add to the increasing understanding of the mechanism of 
UV radi ation-induced immunosuppression and bring us closer to 
manipulation o f human delayed hypersensitivity. 
How Do Dysplastic N evi Become Malignant? 
Noz et al have found (p. 1198) that dysplastic nevus cells are more 
susceptible i ll 1';(1'0 to DNA strand breaks by UVB radiation than are 
common nevus cells or melanocytes. In earlier attempts to deter-
mine hovv dysplastic nevus cells might be damaged by UV radia-
tion, these investigators were surprised to find that dysplastic nevus 
cells were less susceptibl e to indu ction of thymine dim ers than were 
otber types ofmelanocytic cells. In this study, the <l uthors cxamined 
a diflcrcnt kind of DNA damage, DNA strand breaks . By means of 
the comet assay, w hich measures movement of DNA out of the 
nuclei of single cells in an aga rose gel exposed to an electric field , 
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the authors fO Lind that dysplastic nevus cells showed streamjng of 
the DNA (like the ta il of a co l11 cc). evidence of broken strands. 
even in the absen ce of UV irradiati on. Furthermore, m odest doses 
of UVB caused this type of damage in dysplastic nevus ce lls w ith a 
higher freq uen cy than in fo reskin melanocytes o r o rdinary nevus 
ce lls. T his fi nding was unexpected, beca use most mammalian cells 
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do not develop DNA strand breaks except with ve ry high doses of 
UVB, although they can be found afte r UVA irradiation . Since 
DNA strand breaks ca n be ca used by oxjdative dam age, the data 
raise the in tri guing possibility that ox idative DNA damage could be 
important in the pathogenesis of melanoma. 
CD44 Expression in Normal M elanocytes 
H erbo ld ci al (p. 1230) report that CD44 is present on the surf.1ce 
of cul tul'ed human mclanocytes, both in its p roteoglycan and 
non-proteoglycan forms. Sin ce the fi rst report that CD44 mi ght be 
actively invo lved in tumor metastasis , numerous groups have 
looked for correlation between CD44 expression and behavior of 
melanoma. A chondroitin sul f.1te fo rm of CD44 in particular has 
been associated with in vas ive beha vior ;11 Il ilro, and high ex pression 
of CD44 has been corre lated w ith m etastatic potentia l ;11 ";",,. 
Before such co rrelation can be so lidified. it is importan t to have a 
thorough knowledge of C D44 express ion in no rm al m elanocytes. 
T his provoked Milstone's group, w hich had previous ly discovered 
a heparan sul fate fo rm of CD44 on nonna l ke ratinocytes, to 
examine in deta il the fo rms of CD44 expressed by no rmal 111 e la-
nocytes. Many difFe rent forms ofCD44 can be generated in cells by 
alte rnative splic ing of the C D44 gene transcript and by variable 
g lycosylation o f the expressed protein . 13y using the polymerase 
chain reaction along with biochemical and i1111llunochemical tech-
niques. the in vestiga tors demonstra ted that CD44 is present in 
normal m elanocytes and furth e rmore that two forms of CD44 can 
be fo un d. Both form s have the sa m e core protein (CD44H, the 
standard form). and a substantial po rtion of this CD44 is e"-pressed 
as a chondroitin sul fate proteoglycan . Sin ce CD44 can serve as a 
receptor for hya luronan, their findings raise the possibility that the 
dendl'ites of normal melanocytes might use CD44 to " invade" the 
hyaluron<1n-rich in tercellular space be tween keratinocytes. These 
da ta also raise a caution ary flag about correla tions between CD44 
express ion and malignant behav io r; to be m eaningful. such corre-
lations probably shou ld in clu de a comparison w ith the types of 
CD44 ex pressed in no rmal ce lls. 
Human Dermal Fibroblast Cells Express Prolactin In V itro 
Richards and Hartm an (p. 1250) ha ve dem onstrated a poten tia l 
loca l source of pro lactin in ski n. It is known that pro lactin is 
expressed ;11 1/;lro by fibrobla st-like uterin e endometl'ial stroma l ce ll s 
cultured in th e presence ofm edroxyprogestcrone acetate, estradio l, 
and pros tag land in E2 (PGE2) or its second messenger, cyclic- AMP. 
Recently, the autho rs reported a similar patte rn of prolactin 
expression fo r term decidual fibroblasts cultured under ti, e sa me 
condi tions . Pro la ctin also appears to be expressed by fibrob last ce lls 
of conn ective tissu es, but its expression is dep ndent on prostaglan-
din synthesis. T hese observations led the investigators to ask 
w hether pro lactin might be produced in the skin. To approach this 
question , they determin ed whether derm al fibrobl as ts express 
pro lactin i ll lli l ro. T hey cul tured dermal fib roblasts for up to 30 days 
in m edium supplemen ted Witll various com binations of medroxy-
progesterone acetate and es tradiol, PGE2, and cycl ic-AMP and 
looked for pro lacti n by radioimmunoassay, western blot, and 
Northern blot analys is. Prolactin w as indeed presen t in conflu ent 
cul tures of dermal fibrob lasts. Medroxyprogesteron e acetate and 
estradio l had no effect on pro lactin expression but acted syn ergis-
tica lly in combin ation with PGE2 or dibutyryl-cydic-AMP to 
stimulate pro lactin expression , and both P GE2 and dibutyryl-cyclic-
AMP also stimula ted prolactin expression w hen added alone. In 
analogy with the differen tiation of fib roblast-like endometrial Stro-
mal ce lls ;11 ";110 , wh ich has som e features o f an acute inflammatory 
respo nse, de rmal fibrobl ast prolac tin may be induced by factors 
in volved in inflammation associated w ith wound healing. The 
observation that pro lactin stimulates keratinocyte proli feration ill 
11;1 1'0 suggests a role fo r dermal fibrob last prolactin in m esenchym al-
epithelial ce Ll in te ractions of skin and poss ibly in patl]ologic con-
ditions. Derma l fibrob lasts pl;med by appropriate m ediators mjght 
secrete prolactin and stimulate pro liferation of keratinocytes in tile 
epidermis. 
T he 6 - 4 DNA Photoproduct Is Rernoved 15 T imes Faster T han Are T hymine Dimers In Human 
Epidermis In VillO 
Young cl al (p. 1307) have found m~or diffe rences in the removal 
rate of two types of UV-induced DNA ba se changes in human 
epidermis ;11 11;110. T he ab ili ty to repa ir DNA has long been thought 
to be a maj o r facto r in susceptibili ty to ski n cancer. Patients with 
xeroderma pigmentoslIm who are unable to repair DNA normally 
have an extreme ly high rate of basa l and sq uamous cell carcinoma s 
and m elanoma. UV rad ia tion produ ces characteristic changes in 
DNA in clu d ing 6-4 photoprodu cts, altered bases with abn ormal 
linkages be tween the 6 and 4 positions of adjacent pyrimidines, and 
thymin e- thY111ine di111 crs (TT), pyrimidines linked abnormally by a 
cyclobutanc ring. Previous ;11 "ifro and anima l studies have shown 
that 6 -4 photop roducts are repaired fa ster than cyclobutane py-
rimidine dimers (C PO) , but this has not been ve l'ifi ed in hum an 
epidennis. Young ef (/1 compared ti,e speed of decay of6 - 4 and TT 
photoproduc ts il1110rma l volunteers after 2 111 ini111 al e rythem a doses 
of solar-sim ulating rad iation . Skin biopsies taken between a few 
minutes and on e week after such rad iation were sta ined with 
monoclonal antibodies specific for TT or 6-4 photoproducts and 
assessed by quantitative image ana lysis. The ;11 IJilJO half-life of the 
6-4 photoprodu ct was only 2.3 hours, w hil e tllat of the TT 
ph otoprodu ct waS 33.3 ho urs. T he 6- 4 photoproduct appears to be 
preferentiall y repa ired. therefore, and its rapid repair may protect 
the epide rmis fro111 neoplasia. Because ;11 1/ ;1/'0 experiments show 
that it is m ore likc ly to produce a mutation than is C PD, its rapid 
repair might substantially reduce the liklih ood of tumor develop-
ment ;1I 1/;"0. T hi s study involved onl y subjects with skin types I and 
II and reports slower C PD repa ir than previo us studies, in wh.ich 
vo luntee rs m ay have included people w ith skin types III o r IV. TIns 
suggests tl1<l t skin types I and II m ay ha vc slower C PD repair tllan 
types III and IV, a findi ng tha t would accoun t, at least in part. for 
their in creased susceptibili ty to skin ca ncer. 
